PCR Reagents Market
PCR Reagents Market Analysis, By Reagent Type (Primary, Secondary), By Form (Liquid, Powder), By Packaging (Master Mixes, Kits), By Application (Conventional Amplification, Genotyping, Mutation Analysis, Virus Detection, Gene Expression Analysis), By Region - Global Forecast 2022-2032
PCR Reagents Market Outlook (2022-2032)
The global PCR reagents market has reached a valuation of US$ 1.25 billion, registering Y-o-Y growth of 13.4%. As per detailed industry analysis, worldwide demand for PCR reagents is projected to increase at a healthy CAGR of 6.4% over 2022-2032, accounting for more than 40% share of the global polymerase chain reaction market.
PCR Reagents Market Size (2021A)
US$ 1.1 Billion
Estimated Market Value (2022E)
US$ 1.25 Billion
Forecasted Market Value (2032F)
US$ 2.32 Billion
Global Market Growth Rate (2022-2032)
North America Market Share (2021)
East Asia Market Growth Rate (2022-2032)
United States Market Growth Rate (2022-2032)
Market Share of Top 5 Companies
Key Companies Profiled
Interested to Procure The Data
Demand Analysis of PCR Reagents (2017-2021) Vs. Market Forecasts (2022-2032)
Hot start reagents and high fidelity polymerase are two examples of cutting-edge innovations in the PCR reagents sector that are quickly gaining ground in terms of specificity, fidelity, and thermo-stability for biological application. This has directed a 35.7% compound annual growth in the sales of PCR reagents from 2017 to 2021.
The damaging effects of COVID-19 increased the demand for dependable and quick detection systems, which helped the market for PCR reagents boom as RT-PCR, one of the PCR subtypes that require real-time PCR reagents, became extremely useful for the detection of COVID-19.
The market for PCR reagents is anticipated to be fueled by government initiatives to encourage investments in research & development and higher levels of healthcare spending.
Research activities in the field of molecular biology are anticipated to increase as a result of rising demand for technologically-advanced methods for sample preparation, extraction, amplification, and testing for nucleic acids such as DNA and RNA, as well as strategic partnerships between manufacturers and top research institutions.
Fact.MR reveals that the global PCR reagents market will be valued at US$ 2.32 billion by 2032-end, exhibiting a CAGR of 6.4% between 2022 and 2032.
Short Term (2022 Q2 to 2025): Due to a lack of understanding, a declining GDP, and lower healthcare spending in different geographical areas, emerging economies continue to fall behind. High expenses for research and the use of such tests have also negatively influenced the market's growth potential.
The global pandemic impacted research activities due to the disrupted supply chain, thereby affecting the market, though for a short duration of time. This will lead to the slow growth of the global PCR reagents market during the initial forecast years, generating an absolute $ opportunity of US$ 265.2 million over 2022 to 2025.
Medium Term (2025-2028): Significant increase in genetic disorders will drive the adoption of molecular diagnosis, which includes epigenetics, PCR technologies, and many more that require molecular biology enzymes, kits, and reagents, which will ultimately boost demand for PCR reagents.
Since the adoption of molecular diagnosis is surging, demand for polymerase chain reaction reagents will also increase due to their requirement in advanced technologies - Droplet Digital PCR. Over the medium term, the market for PCR reagents is expected to exhibit rapid advancements and increase US$ 323.7 million from 2025 to 2028.
Long Term (2028-2032): Growth prospects will be further improved by increasing investments in genetic engineering research and development and competition in the search for new treatments for diseases such as cancer and HIV/AIDS.
Fact.MR projects an incremental opportunity of US$ 481.5 million over 2028-2032 for the global PCR reagents market.
What’s Driving High Demand for PCR Reagents?
“Need for Early Detection of Diseases Driving Market Growth”
The market for PCR reagents has grown as a result of increased attention being paid to the early detection of genetic disorders and the rising need for human genome editing. The quick uptake of PCR kits during the COVID-19 pandemic emerged as a major driver for the PCR reagent kits market.
With increasing sedentary lifestyles, the incidence of diseases has increased, which is why technology drivers for polymerase chain reaction reagents have shown a great hike. Due to the availability of ready-made mixes and reagents, reagents and consumables have the largest market share in the polymerase chain reaction market in terms of revenue.
Use of polymerase chain reactions (PCR) devices for disease detection has enhanced the PCR reagents market in recent years - PCR reagent mixes, standard PCR reagents, PCR buffers, etc.
An Adaptive Approach to Modern-day Research Needs
What Issue Do PCR Reagent Producers Need to Solve?
“High Cost Associated with PCR Reagents Hampering Market Expansion”
The pandemic significantly harmed the global economy, causing many developing nations to reduce the number of funds available for research. As a result, the market for advanced PCR techniques such as droplet digital PCR is still beyond reach for several economies.
The consequences of this will prevent research institutions and small businesses from using cutting-edge biological procedures such as Next Generation Sequencing (NGS), which will have an impact on the PCR reagents industry as well.
Overall, the market for PCR reagents is anchored by limited affordability and the capital intensiveness of product research and development.
How is the U.S. PCR Reagents Market Faring?
Due to the presence of a well-established healthcare infrastructure, technological advancements, and a sizable number of CMO and bioprocess organizations that will support market expansion over the long term, the United States is likely to hold the top spot in the North American PCR reagents market.
Which is the Leading European Market for PCR Reagents?
With around 6,300 life science enterprises, 80% of which are SMEs, the United Kingdom is regarded as the third-largest global life science cluster. Driving factors include the expansion of healthcare infrastructure and the accessibility of qualified personnel, along with government support that gives a great opportunity for PCR reagent suppliers.
Investment collaborations for research in the U.K also create a favorable environment for the PCR reagents market in the country.
What Allows DNA Polymerase Reagent Type to Dominate the Market?
DNA polymerase dominates with more than 35% share of the global PCR reagents market by reagent type. Although used in minimal quantities, DNA polymerase leads the process of amplification and decides the fidelity of the process.
Improvement of DNA polymerases’ accuracy and efficiency is the result of robust research and development in the molecular and life science industry. Also, the isolation and purification of DNA polymerase is expensive, resulting in high product price and market value share.
How is High Need for Virus Detection Supporting Market Growth?
Expanding commercial end uses have led to the high sales of DNA polymerase over the historical period, and the trend is expected to continue over the forecast period as well.
The hit of the pandemic and the use of PCR as a rapid detection tool attracted innovations in the field to commercialize PCR as a diagnostic tool for several other pathogen and virus detection purposes as well.
The virus detection segment has acquired almost 50% of the global market share in 2022 and is expected to grow further over the coming years.
Avail customized purchase options for your needs
Prominent PCR reagent manufacturers are Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Thermofishers, Biotium, MiRXES Pte Ltd, GeneDireX, Inc., Norgen Biotek Corp, Takara Holdings Inc., Qiagen, PCR Biosystems, Tonbo Biosciences, Quantabio, Kaneka Eurogentec S.A, Promega Corporation, InBios International, Abbott, Siemens Healthcare GmbH, bioMérieux SA, and F. Hoffmann-La Roche AG.
The global PCR reagents market is fairly fragmented with several manufacturers competing for dominance. Demand for reagents used in PCR is expected to increase rapidly due to the ongoing rise in diagnostic tests and the introduction of novel reagents tailored to several test types.
Sales of PCR products such as PCR reagents have been further boosted by the availability of customized PCR reagents that guarantee the effectiveness and accuracy of tests, provided by a few key companies such as Bio-Rad and PCR Bio Systems.
- IsoFast Bst Polymerase reagents from PCR Biosystems were launched in March 2021, supporting sensitive, robust, and quick amplification of RNA and DNA. This allows for quicker testing methods.
- Bio-Rad acquired Celsee, Inc., a single-cell analysis solutions provider, in April 2020. This acquisition will expand Bio-rad’s reach in the rapidly growing world of precision medicine and molecular diagnosis.
Fact.MR has provided detailed information about the price points of key manufacturers of PCR reagents positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
Segmentation of PCR Reagents Industry Research
PCR Reagents Market by Reagent Type :
- Pol Specific Buffer
- Sterile Water
- Magnesium Salt
- Potassium Salt
- Dimethyl sulfoxide (DMSO)
- Bovine Serum Albumin (BSA)
- Form amide
PCR Reagents Market by Form :
- Liquid PCR Reagents
- Powder PCR Reagents
PCR Reagents Market by Packaging :
- Master Mixes
- Master Mixes
PCR Reagents Market by Application :
- Conventional Amplification
- Mutation Analysis
- SNP Loci Amplification
- Virus Detection
- STR and Microsatellite Analysis
- Gene Expression Analysis
- Molecular Cloning
- RNA Detection
PCR Reagents Market by Region :
- North America
- Latin America
- East Asia
- South Asia & ASEAN
- FAQs -
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
The gel documentation systems market to expand at 3.5% CAGR to climb to US$ 317.8 mn by 2026. Gel Do...
The body composition analyzers market will see a high CAGR of 8% to reach US$ 849 mn by 2026. Hydros...
Electronic Health Records Market is expected to reach a value of US$ 41.8 Bn by 2032. Web-based EHR ...